Lista de obras -

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

artículo científico publicado en 2009

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

artículo científico publicado en 2002

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

artículo científico publicado en 2013

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

artículo científico publicado en 2008

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

artículo científico publicado en 2017

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases

artículo científico publicado en 2013

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

artículo científico publicado en 2006

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

artículo científico publicado en 2011

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2004

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

artículo científico publicado en 2013

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

artículo científico publicado en 2002

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation

artículo científico publicado en 2011

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

artículo científico publicado en 2015

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

artículo científico publicado en 2004

Contributors

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

artículo científico publicado en 2005

Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.

artículo científico publicado en 2002

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

artículo científico publicado en 2013

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

artículo científico publicado en 2014

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

artículo científico publicado en 2004

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

scientific article published on 01 November 2003

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

artículo científico publicado en 2015

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

artículo científico publicado en 2005

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

artículo científico publicado en 2011

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

artículo científico publicado en 2005

Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma

artículo científico publicado en 2017

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

artículo científico publicado en 2014

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

scientific article published on 19 February 2019

Genome wide DNA-profiling of HIV-related B-cell lymphomas

artículo científico publicado en 2009

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

artículo científico publicado en 2013

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

artículo científico publicado en 2019

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

artículo científico publicado en 2012

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

artículo científico publicado en 2010

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

artículo científico publicado en 2014

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen

artículo científico publicado en 2002

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

artículo científico publicado en 2015

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

artículo científico publicado en 2015

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2010

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

artículo científico publicado en 2011

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

artículo científico publicado en 2015

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

artículo científico publicado en 2005

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

artículo científico

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2014

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

artículo científico publicado en 2012

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

artículo científico publicado en 2009

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

artículo científico publicado en 2006

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

artículo científico publicado en 2007

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

artículo científico

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma ⬇️

artículo científico publicado el 15 de abril de 2003

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

artículo científico publicado en 2007

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

scientific article published on 01 December 2019

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy

artículo científico

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

article by Andrea Rinaldi et al published 3 March 2010 in British Journal of Haematology

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma

artículo científico publicado en 2019

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

artículo científico publicado en 2008

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

article

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

artículo científico publicado en 2002

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.

artículo científico publicado en 2013

Lista de obras de

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma

CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience

Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Contributors

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group

Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma

Follicular large cleaved cell (centrocytic) lymphoma: An unrecognized variant of follicular lymphoma

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Genome wide DNA-profiling of HIV-related B-cell lymphomas

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

Integrated profiling of diffuse large B-cell lymphoma with 7q gain

Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

Molecular diagnosis of Burkitt's lymphoma

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma ⬇️

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry

Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy

Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma

Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.